Biocodex Microbiota Foundation Announces $50,000 USA Microbiome Research Grant

10th anniversary grant marks $500,000 in total support for U.S. gut microbiome research

Published on Feb. 23, 2026

Got story updates? Submit your updates here. ›

The Biocodex Microbiota Foundation, an independent organization founded by Biocodex, has opened applications for its 2026 USA research grant. The $50,000 grant, selected by a panel of medical and scientific experts, will be awarded to a U.S.-based investigator studying the gut microbiota and its relationship to human health and disease. The Foundation has awarded $500,000 in grants to U.S. researchers since 2017, underscoring its long-term commitment to advancing microbiome science.

Why it matters

Microbiome research continues to transform our understanding of health and disease, offering revolutionary diagnostic and therapeutic opportunities. The Biocodex Microbiota Foundation's grant program helps catalyze research that translates into better patient outcomes worldwide.

The details

The theme for the 2026 grant is "Harnessing the Gut Microbiome: Impacts on Health, Disease, Diagnosis and Therapeutics." The program will focus on innovative research that leverages the gut microbiome to advance understanding of disease mechanisms, refine diagnostics, and inform novel therapeutic strategies across a spectrum of conditions. The grant, applicable to new or ongoing studies, will be awarded in July 2026. The ideal candidate is a U.S.-based researcher with five or fewer years of experience in microbiota research, seeking to establish themselves as an independent investigator.

  • The submission deadline is May 22, 2026.
  • The grant will be awarded in July 2026.

The players

Biocodex Microbiota Foundation

An independent organization founded by Biocodex with a mission to support research into microbiota and its interaction with various pathologies.

Marie-Emmanuelle LeGuern

Chairman of the Biocodex Microbiota Foundation.

Dr. Leah Beauchamp

A Postdoctoral Fellow at Brigham and Women's Hospital and Harvard Medical School, and the 2025 grant recipient.

Dr. Ruth Ann Luna

A member of the U.S. Biocodex Microbiota Foundation's scientific board, affiliated with Texas Children's Hospital and Baylor College of Medicine.

Dr. Mindy Engevik

A member of the U.S. Biocodex Microbiota Foundation's scientific board, affiliated with the Medical University of South Carolina.

Dr. Erica Sonnenburg

A member of the U.S. Biocodex Microbiota Foundation's scientific board, affiliated with Stanford University.

Got photos? Submit your photos here. ›

What they’re saying

“This grant provides me with the resources to continue and expand our work at the gut–brain interface in Parkinson's disease. With support from the Biocodex Microbiota Foundation, we can build on our findings to better understand how microbiome changes and early brain inflammation may shape one another—insights that could help inform earlier, more targeted strategies to protect neurons before they are lost.”

— Dr. Leah Beauchamp, Postdoctoral Fellow (Biocodex Microbiota Foundation)

“Grants from the Foundation reinforce our commitment to early-career researchers and their innovative projects. Microbiome research continues to transform our understanding of health and disease, offering revolutionary diagnostic and therapeutic opportunities. As we mark the 10th anniversary of this grant, we are proud to help catalyze research that translates into better patient outcomes worldwide.”

— Marie-Emmanuelle LeGuern, Chairman (Biocodex Microbiota Foundation)

What’s next

The ideal 2026 grant candidate is a U.S.-based researcher with five or fewer years of experience in microbiota research, seeking to establish themselves as an independent investigator. Completed applications must be submitted to [email protected] by May 22, 2026.

The takeaway

The Biocodex Microbiota Foundation's grant program demonstrates a long-term commitment to advancing microbiome science and its impact on patient care, supporting early-career researchers and their innovative projects that have the potential to transform our understanding of health and disease.